HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Class-Action Suit Targets Firm Fighting Aging Via Telomerase Activation

This article was originally published in The Rose Sheet

Executive Summary

Telomerase Activation Sciences, Inc. makes claims that are “knowingly false” and fails to warn consumers about the potential risks associated with its T.A. 65 supplement, according to a class-action suit filed by a former employee.

You may also be interested in...



Telometrics Claims Vital-25 Anti-Aging Enzyme Supplement “Resets” Cells

Telometrics Corporation recommends that consumers drink one $600 vial of its Vital-25 Anti-Aging Formula dietary supplement twice a year for a “full-body reset” at the cellular level.

T.A. Sciences Developing Cosmeceutical With Molecule That Prolongs Cell Life

Nutraceutical marketer T.A. Sciences is developing a skin-care product based on the molecule TA-65, which it says maintains or increases the length of telomeres - genetic elements believed to play a central role in cell aging

FTC Notifies ReJuvenation ‘Anti-Aging’ Pill Purchasers To Expect (Or Request) Mailed Refunds

The sellers of the anti-aging “cure-all” reached an agreement with the FTC in February that prohibits them from making false and unsubstantiated health claims and requires them to pay $660,000 in total to the Commission. Refund checks now are being issued to more than 1,300 defrauded consumers.

UsernamePublicRestriction

Register

GB149896

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel